The Effect of Extracorporeal Shock Wave Therapy on Spasticity
- Conditions
- Spasticity
- Interventions
- Device: Shock wave
- Registration Number
- NCT02221011
- Lead Sponsor
- Tri-Service General Hospital
- Brief Summary
The effect of traditional treatment for spasticity is barely satisfactory. The shock wave has been used to treat the spasticity with expressively response and the effect could persist for 1-3 months in different studies. However most sutdies lack the sham or control group. The purpose of this study was to assess the effect of shock wave for spasticity in wrist and hand.
- Detailed Description
The patients with spasticity for at least 6 months were randomized for 3 groups. Group I: patients receive one session of shock wave per week for 3 weeks; Group II: patients receive only one session of shock wave; Group III: patients receive the sham shock wave per week for 3 weeks. The outcome measurements include Modified Asthow scale, passive range of motion, Disability Assessment Scale and Fugl-Meyer Assessment Scale (hand function and wrist control).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Age between 20-80 year-old Spasticity measured as Modified Asthow Scale more than 1+ point and persist at least 6 months Clear consciousness No receive Phenol injection or Botulinum toxin in past 6 months
Cancer Joint contracture Coagulopathy Pregnancy Pacemaker Inflammation status
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Shock wave (one time) Shock wave E-SWT, Elettronica Pagani, Italy 3.5 bars 1500 beats in FCU, FCR 3 bars 4000 beats diffuse in intrinsic muscle Only one dose Sham shock wave Shock wave E-SWT, Elettronica Pagani, Italy Sham without energy, 1500 beats in FCU, FCR and 4000 beats diffuse in intrinsic muscle shock wave (three times) Shock wave E-SWT, Elettronica Pagani, Italy 3.5 bars 1500 beats in FCU, FCR 3 bars 4000 beats diffuse in intrinsic muscle Once a week for 3 weeks
- Primary Outcome Measures
Name Time Method Change from baseline of spasticity on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Using the modyfied Ashworth Scale to measure the spasticity before treatment and multiple time frame after treatment.
- Secondary Outcome Measures
Name Time Method Change from baseline of disability on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Using the Disability Assessment Scale to measure the disabilty scale before treatment and multiple time frame after treatment.
Change from baseline of range of motion on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Using the digital goniometer to measure the passive range of motion before treatment and multiple time frame after treatment.
Change from baseline of pain on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment. Using the Visual analog scale (VAS) to measure the pain from spasticity scale before treatment and multiple time frame after treatment.
Trial Locations
- Locations (1)
Tri-Service General Hospital National Defense Medical Center
🇨🇳Taipei, Neihu, Taiwan